Pietro Morrone
Cosenza, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Real-Life Effectiveness of Abrocitinib and Predictors of Response in Adults With Moderate-To-Severe Atopic Dermatitis.
Journal: International journal of dermatology
Published: November 17, 2025
Upadacitinib is efficacious in reducing the alexithymic trait in adult patients with moderate-to-severe atopic dermatitis: a prospective multicenter real-life study.
Journal: Italian journal of dermatology and venereology
Published: October 03, 2025
Psoriasis and seronegative spondyloarthropathy in patients with atopic dermatitis treated with dupilumab or tralokinumab: a multicentre observational study.
Journal: Clinical and experimental dermatology
Published: July 01, 2025
New Perspectives on Nutraceutical Insulin Sensitizing Agents in the Treatment of Psoriasis and Other Dermatological Diseases.
Journal: International journal of molecular sciences
Published: June 14, 2025
Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study.
Journal: International journal of dermatology
Published: May 21, 2025
Risk Assessment in Atopic Dermatitis: Guidance from a Multidisciplinary Expert Panel.
Journal: Dermatology and therapy
Published: February 13, 2025
Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: results from a 16-week real-world multicenter retrospective study - il AD (Italian landscape atopic dermatitis).
Journal: The Journal of dermatological treatment
Published: October 10, 2024
The risk of candidiasis during treatment with bimekizumab for the management of plaque psoriasis: a 16-week multicentre real-world experience - IL PSO (Italian Landscape Psoriasis).
Journal: Clinical and experimental dermatology
Published: September 15, 2024
Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World Evidence.
Journal: Dermatology and therapy
Published: April 30, 2024
Drug Survival of Upadacitinib and Predicting Factors of Discontinuation in Adult Patients Affected by Moderate-to-Severe Atopic Dermatitis: An Italian Multicenter Analysis.
Journal: Journal of clinical medicine
Published: December 24, 2023
Guidelines How to Integrate Surgery and Targeted Therapy with Biologics for the Treatment of Hidradenitis Suppurativa: Delphi Consensus Statements from an Italian Expert Panel.
Journal: Dermatology (Basel, Switzerland)
Published: May 17, 2023
Hidradenitis suppurativa and psoriasis: the odd couple.
Journal: Frontiers in medicine
Published: April 19, 2023
Last Updated: 09/26/2026